Key market opportunities for bispecific antibody drug conjugates (BsADCs) include their potential to revolutionize cancer treatment by targeting dual antigens, addressing tumor heterogeneity. With ...

The bispecific antibodies market presents growth opportunities in cancer, autoimmune, and inflammatory therapies, driven by robust clinical progress, technological innovation, and strategic ...

In results posted today, Roche’s investigational Alzheimer’s Disease biologic, gantenerumab, did not reduce cognitive decline to a statistically significant degree compared to placebo. The cognitive ...

Antibodies, also known as immunoglobulins, are specialized proteins produced by the immune system to identify and neutralize foreign invaders, such as viruses, bacteria, and other pathogens. They are ...

This first-in-man trial conducted by Onward Therapeutics, under the license and co-development agreement, is a Phase 1 clinical trial for the evaluation of a bispecific antibody generated from ...

iBio announces licensing agreement with AstralBio for a novel antibody targeting Activin E, potentially aiding weight loss and cardiometabolic health. Bio, Inc. has announced a licensing agreement ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to a ...

UAB researchers discover that the immune system consistently targets the same region of mismatched HLA proteins after organ ...

The mammalian immune system produces a range of antibody types in order to protect the host from the daily onslaught of foreign invaders. These various antibody classes typically have well-defined ...